Cargando…
The new oral anti-coagulants and the phase 3 clinical trials - a systematic review of the literature
BACKGROUND: Anticoagulation with vitamin K antagonists such as warfarin has historically been used for the long term management of patients with thromboembolic disease. However, these agents have a slow onset of action which requires bridging therapy with heparin and its analogues, which are availab...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766654/ https://www.ncbi.nlm.nih.gov/pubmed/24007323 http://dx.doi.org/10.1186/1477-9560-11-18 |